SEARCH

SEARCH BY CITATION

References

  • Ambroziak K, Kuteykin-Teplyakov K, Luna-Tortos C, Al-Falah M, Fedrowitz M, Loscher W. (2010) Exposure to antiepileptic drugs does not alter the functionality of P-glycoprotein in brain capillary endothelial and kidney cell lines. Eur J Pharmacol628:5766.
  • Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, Spain W. (2002) Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol59:781786.
  • Annegers JF, Hauser WA, Shirts SB. (1984) Heart disease mortality and morbidity in patients with epilepsy. Epilepsia25:699704.
  • Apeland T, Mansoor MA, Strandjord RE, Kristensen O. (2000) Homocysteine concentrations and methionine loading in patients on antiepileptic drugs. Acta Neurol Scand101:217223.
  • Attilakos A, Papakonstantinou E, Schulpis K, Voudris K, Katsarou E, Mastroyianni S, Garoufi A. (2006) Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy. Epilepsy Res71:229232.
  • Back DJ, Bates M, Bowden A, Breckenridge AM, Hall MJ, Jones H, MacIver M, Orme M, Perucca E, Richens A, Rowe PH, Smith E. (1980) The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy. Contraception22:495503.
  • Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, Nishtar S, Norrving B, Patterson D, Piot P, Ralston J, Rani M, Reddy KS, Sassi F, Sheron N, Stuckler D, Suh I, Torode J, Varghese C, Watt J. (2011) Priority actions for the non-communicable disease crisis. Lancet377:14381447.
  • Belcastro V, Striano P, Gorgone G, Costa C, Ciampa C, Caccamo D, Pisani LR, Oteri G, Marciani MG, Aguglia U, Striano S, Ientile R, Calabresi P, Pisani F. (2010) Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Epilepsia51:274279.
  • Besag FM, Berry D. (2006) Interactions between antiepileptic and antipsychotic drugs. Drug Saf29:95118.
  • Beyenburg S, Stavem K, Schmidt D. (2012) Placebo-corrected efficacy of modern nonenzyme-inducing AEDs for refractory focal epilepsy: systematic review and meta-analysis. Epilepsia53:512520.
  • Birbeck GL, French JA, Perucca E, Simpson DM, Fraimow H, George JM, Okulicz JF, Clifford DB, Hachad H, Levy RH. (2012) Evidence-based guideline: antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy. Neurology78:139145.
  • Bock KW. (2010) Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels. Biochem Pharmacol80:771777.
  • Botts S, Diaz FJ, Santoro V, Spina E, Muscatello MR, Cogollo M, Castro FE, de Leon J. (2008) Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model. Prog Neuropsychopharmacol Biol Psychiatry32:14531458.
  • Bramswig S, Sudhop T, Luers C, von Bergmann K, Berthold HK. (2003) Lipoprotein(a) concentration increases during treatment with carbamazepine. Epilepsia44:457460.
  • Brodie MJ. (2010) Antiepileptic drug therapy the story so far. Seizure19:650655.
  • Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ. (2007) Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology68:402408.
  • Brodie MJ, Barry SJ, Bamagous GA, Norrie JD, Kwan P. (2012) Patterns of treatment response in newly diagnosed epilepsy. Neurology78:15481554.
  • Brophy TR, McCafferty J, Tyrer JH, Eadie MJ. (1983) Bioavailability of oral dexamethasone during high dose steroid therapy in neurological patients. Eur J Clin Pharmacol24:103108.
  • Bullman J, Nicholls A, Van Landingham K, Fleck R, Vuong A, Miller J, Alexander S, Messenheimer J. (2011) Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers. Epilepsia52:13511358.
  • Candrilli SD, Manjunath R, Davis KL, Gidal BE. (2010) The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsy. Epilepsy Res91:260266.
  • Carbone LD, Johnson KC, Robbins J, Larson JC, Curb JD, Watson K, Gass M, Lacroix AZ. (2010) Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women’s health initiative (WHI). J Bone Miner Res25:873881.
  • Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. (2005) Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet365:224232.
  • Chalk JB, Ridgeway K, Brophy T, Yelland JD, Eadie MJ. (1984) Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry47:10871090.
  • Chang SM, Kuhn JG, Rizzo J, Robins HI, Schold SC Jr, Spence AM, Berger MS, Mehta MP, Bozik ME, Pollack I, Gilbert M, Fulton D, Rankin C, Malec M, Prados MD. (1998) Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol16:21882194.
  • Chuang YC, Chuang HY, Lin TK, Chang CC, Lu CH, Chang WN, Chen SD, Tan TY, Huang CR, Chan SH. (2012) Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia53:120128.
  • Cloughesy TF, Kuhn J, Robins HI, Abrey L, Wen P, Fink K, Lieberman FS, Mehta M, Chang S, Yung A, DeAngelis L, Schiff D, Junck L, Groves M, Paquette S, Wright J, Lamborn K, Sebti SM, Prados M. (2005) Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. J Clin Oncol23:66476656.
  • Cloughesy TF, Wen PY, Robins HI, Chang SM, Groves MD, Fink KL, Junck L, Schiff D, Abrey L, Gilbert MR, Lieberman F, Kuhn J, DeAngelis LM, Mehta M, Raizer JJ, Yung WK, Aldape K, Wright J, Lamborn KR, Prados MD. (2006) Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. J Clin Oncol24:36513656.
  • Cooney GF, Mochon M, Kaiser B, Dunn SP, Goldsmith B. (1995) Effects of carbamazepine on cyclosporine metabolism in pediatric renal transplant recipients. Pharmacotherapy15:353356.
  • Crawford P. (2002) Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs16:263272.
  • Crawford P, Chadwick DJ, Martin C, Tjia J, Back DJ, Orme M. (1990) The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids. Br J Clin Pharmacol30:892896.
  • Dana-Haeri J, Oxley J, Richens A. (1984) Pituitary responsiveness to gonadotrophin-releasing and thyrotrophin-releasing hormones in epileptic patients receiving carbamazepine or phenytoin. Clin Endocrinol (Oxf)20:163168.
  • Davis AR, Westhoff CL, Stanczyk FZ. (2011) Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation, and bleeding. Epilepsia52:243247.
  • Ding D, Wang W, Wu J, Ma G, Dai X, Yang B, Wang T, Yuan C, Hong Z, de Boer HM, Prilipko L, Sander JW. (2006) Premature mortality in people with epilepsy in rural China: a prospective study. Lancet Neurol5:823827.
  • D’Souza MJ, Pollock SH, Solomon HM. (1988) Cyclosporine-phenytoin interaction. Drug Metab Dispos16:256258.
  • Duncan S, Blacklaw J, Beastall GH, Brodie MJ. (1999) Antiepileptic drug therapy and sexual function in men with epilepsy. Epilepsia40:197204.
  • Eiris J, Novo-Rodriguez MI, Del Rio M, Meseguer P, Del Rio MC, Castro-Gago M. (2000) The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res41:17.
  • El-Hajj FG, Dib L, Yamout B, Sawaya R, Mikati MA. (2008) Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone43:149155.
  • Fakhoury TA, Hammer AE, Vuong A, Messenheimer JA. (2004) Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy. Epilepsy Behav5:532538.
  • Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj FG. (2002) Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology58:13481353.
  • Fetell MR, Grossman SA, Fisher JD, Erlanger B, Rowinsky E, Stockel J, Piantadosi S. (1997) Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium. J Clin Oncol15:31213128.
  • Fleishaker JC, Pearson LK, Peters GR. (1995) Phenytoin causes a rapid increase in 6 beta-hydroxycortisol urinary excretion in humans--a putative measure of CYP3A induction. J Pharm Sci84:292294.
  • French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA. (2004) Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology62:12521260.
  • Frey BM, Frey FJ. (1984) Phenytoin modulates the pharmacokinetics of prednisolone and the pharmacodynamics of prednisolone as assessed by the inhibition of the mixed lymphocyte reaction in humans. Eur J Clin Invest14:16.
  • Gaitatzis A, Carroll K, Majeed A, Sander W. (2004) The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia45:16131622.
  • Galimberti CA, Magri F, Copello F, Arbasino C, Cravello L, Casu M, Patrone V, Murialdo G. (2005) Seizure frequency and cortisol and dehydroepiandrosterone sulfate (DHEAS) levels in women with epilepsy receiving antiepileptic drug treatment. Epilepsia46:517523.
  • Galimberti CA, Magri F, Copello F, Arbasino C, Chytiris S, Casu M, Ameri P, Perucca P, Murialdo G. (2009) Changes in sex steroid levels in women with epilepsy on treatment: relationship with antiepileptic therapies and seizure frequency. Epilepsia50(Suppl. 1):2832.
  • Ghosh C, Gonzalez-Martinez J, Hossain M, Cucullo L, Fazio V, Janigro D, Marchi N. (2010) Pattern of P450 expression at the human blood-brain barrier: roles of epileptic condition and laminar flow. Epilepsia51:14081417.
  • Gibbons GF. (2002) The role of cytochrome P450 in the regulation of cholesterol biosynthesis. Lipids37:11631170.
  • Gidal BE, French JA, Grossman P, Le Teuff G. (2009) Assessment of potential drug interactions in patients with epilepsy: impact of age and sex. Neurology72:419425.
  • Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T. (2006) ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia47:10941120.
  • Grossman SA, Hochberg F, Fisher J, Chen TL, Kim L, Gregory R, Grochow LB, Piantadosi S. (1998) Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy. Cancer Chemother Pharmacol42:118126.
  • Hahn TJ, Birge SJ, Scharp CR, Avioli LV. (1972) Phenobarbital-induced alterations in vitamin D metabolism. J Clin Invest51:741748.
  • Hamed SA, Hamed EA, Hamdy R, Nabeshima T. (2007) Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res74:183192.
  • Hassan M, Oberg G, Bjorkholm M, Wallin I, Lindgren M. (1993) Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics. Cancer Chemother Pharmacol33:181186.
  • Herzog AG, Drislane FW, Schomer DL, Pennell PB, Bromfield EB, Dworetzky BA, Farina EL, Frye CA. (2005) Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology65:10161020.
  • Herzog AG, Drislane FW, Schomer DL, Pennell PB, Bromfield EB, Dworetzky BA, Farina EL, Frye CA. (2006) Differential effects of antiepileptic drugs on neuroactive steroids in men with epilepsy. Epilepsia47:19451948.
  • Hoppe C, Elger CE. (2011) Depression in epilepsy: a critical review from a clinical perspective. Nat Rev Neurol7:462472.
  • Imai H, Kotegawa T, Tsutsumi K, Morimoto T, Eshima N, Nakano S, Ohashi K. (2008) The recovery time-course of CYP3A after induction by St John’s wort administration. Br J Clin Pharmacol65:701707.
  • Isojarvi JI. (1990) Serum steroid hormones and pituitary function in female epileptic patients during carbamazepine therapy. Epilepsia31:438445.
  • Isojarvi JI, Pakarinen AJ, Myllyla VV. (1991) A prospective study of serum sex hormones during carbamazepine therapy. Epilepsy Res9:139144.
  • Isojarvi JI, Pakarinen AJ, Myllyla VV. (1993) Serum lipid levels during carbamazepine medication. A prospective study. Arch Neurol50:590593.
  • Isojarvi JI, Pakarinen AJ, Rautio A, Pelkonen O, Myllyla VV. (1994) Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine. Epilepsia35:12171220.
  • Isojarvi JI, Repo M, Pakarinen AJ, Lukkarinen O, Myllyla VV. (1995) Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy. Epilepsia36:366370.
  • Isojarvi JI, Lofgren E, Juntunen KS, Pakarinen AJ, Paivansalo M, Rautakorpi I, Tuomivaara L. (2004) Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology62:247253.
  • Jaeckle KA, Ballman K, Furth A, Buckner JC. (2009) Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. Neurology73:12071213.
  • Joerger M, Schellens JH, Beijnen JH. (2004) Therapeutic drug monitoring of non-anticancer drugs in cancer patients. Methods Find Exp Clin Pharmacol26:531545.
  • Kanebratt KP, Andersson TB. (2008) HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans. Drug Metab Dispos36:137145.
  • Kenyon IE. (1972) Unplanned pregnancy in an epileptic. Br Med J1:686687.
  • Kerr MP, Mensah S, Besag F, de Toffol B, Ettinger A, Kanemoto K, Kanner A, Kemp S, Krishnamoorthy E, LaFrance WC Jr, Mula M, Schmitz B, van Elst LT, Trollor J, Wilson SJ. (2011) International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia52:21332138.
  • Kiang TK, Ensom MH, Chang TK. (2005) UDP-glucuronosyltransferases and clinical drug–drug interactions. Pharmacol Ther106:97132.
  • Kim RB. (2002) Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab Rev34:4754.
  • Kim SH, Lee JW, Choi KG, Chung HW, Lee HW. (2007) A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav10:291295.
  • Kuhn JG, Chang SM, Wen PY, Cloughesy TF, Greenberg H, Schiff D, Conrad C, Fink KL, Robins HI, Mehta M, DeAngelis L, Raizer J, Hess K, Lamborn KR, Dancey J, Prados MD. (2007) Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma. Clin Cancer Res13:74017406.
  • Lackner TE. (1991) Interaction of dexamethasone with phenytoin. Pharmacotherapy11:344347.
  • L’homme RF, Dijkema T, van der Ven AJ, Burger DM. (2006) Brief report: enzyme inducers reduce elimination half-life after a single dose of nevirapine in healthy women. J Acquir Immune Defic Syndr43:193196.
  • Li AP, Kaminski DL, Rasmussen A. (1995) Substrates of human hepatic cytochrome P450 3A4. Toxicology104:18
  • Lim ML, Min SS, Eron JJ, Bertz RJ, Robinson M, Gaedigk A, Kashuba AD. (2004) Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction. J Acquir Immune Defic Syndr36:10341040.
  • Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, Chang S, Lamborn KR, McDermott MW. (2009) Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol93:349354.
  • Linnebank M, Moskau S, Semmler A, Widman G, Stoffel-Wagner B, Weller M, Elger CE. (2011) Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol69:352359.
  • Liu D, Dillon JS. (2002) Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J Biol Chem277:2137921388.
  • Lombardo L, Pellitteri R, Balazy M, Cardile V. (2008) Induction of nuclear receptors and drug resistance in the brain microvascular endothelial cells treated with antiepileptic drugs. Curr Neurovasc Res5:8292.
  • Lopinto-Khoury C, Mintzer S. (2010) Antiepileptic drugs and markers of vascular risk. Curr Treat Options Neurol12:300308.
  • Lossius MI, Tauboll E, Mowinckel P, Morkrid L, Gjerstad L. (2007) Reversible effects of antiepileptic drugs on reproductive endocrine function in men and women with epilepsy – a prospective randomized double-blind withdrawal study. Epilepsia48:18751882.
  • Lucas RA, Gilfillan DJ, Bergstrom RF. (1998) A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism. Eur J Clin Pharmacol54:639643.
  • Luoma PV, Sotaniemi EA, Arranto AJ. (1983) Serum LDL cholesterol, the LDL/HDL cholesterol ratio and liver microsomal enzyme induction evaluated by antipyrine kinetics. Scand J Clin Lab Invest43:671675.
  • Luoma PV, Sotaniemi EA, Pelkonen RO, Pirttiaho HI. (1985) Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes. Eur J Clin Pharmacol28:615618.
  • Magnusson MO, Dahl ML, Cederberg J, Karlsson MO, Sandstrom R. (2008) Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin. Clin Pharmacol Ther84:5262.
  • Marini S, Nannelli A, Sodini D, Dragoni S, Valoti M, Longo V, Gervasi PG. (2007) Expression, microsomal and mitochondrial activities of cytochrome P450 enzymes in brain regions from control and phenobarbital-treated rabbits. Life Sci80:910917.
  • Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR. (2007) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet369:10001015.
  • di Masi A, De Marinis E, Ascenzi P, Marino M. (2009) Nuclear receptors CAR and PXR: molecular, functional, and biomedical aspects. Mol Aspects Med30:297343.
  • McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. (2002) Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke33:23512356.
  • Medical Research Council Antiepileptic Drug Withdrawal Study Group. (1991) Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet337:11751180.
  • Mintzer S, Mattson RT. (2009) Should enzyme-inducing antiepileptic drugs be considered first-line agents?Epilepsia50(Suppl. 8):4250.
  • Mintzer S, Skidmore CT, Abidin CJ, Morales MC, Chervoneva I, Capuzzi DM, Sperling MR. (2009) Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann Neurol65:448456.
  • Mintzer S, Skidmore CT, Rankin SJ, Chervoneva I, Pequinot E, Capuzzi DM, Sperling MR. (2012) Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein. Epilepsy Res98:8893.
  • Morrell MJ, Flynn KL, Seale CG, Done S, Paulson AJ, Flaster ER, Ferin M. (2001) Reproductive dysfunction in women with epilepsy: antiepileptic drug effects on sex-steroid hormones. CNS Spectr6:771786.
  • Morrell MJ, Flynn KL, Done S, Flaster E, Kalayjian L, Pack AM. (2005) Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs. Epilepsy Behav6:360365.
  • Mu J, Liu L, Zhang Q, Si Y, Hu J, Fang J, Gao Y, He J, Li S, Wang W, Wu J, Sander JW, Zhou D. (2011) Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology77:132137.
  • Mula M. (2008) Anticonvulsants – antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology. Curr Drug Metab9:730737.
  • Murialdo G, Galimberti CA, Gianelli MV, Rollero A, Polleri A, Copello F, Magri F, Ferrari E, Sampaolo P, Manni R, Tartara A. (1998) Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy. Clin Neuropharmacol21:5258.
  • Muuronen A, Kaste M, Nikkila EA, Tolppanen EM. (1985) Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case–control study. Br Med J (Clin Res Ed)291:14811483.
  • Nallani SC, Glauser TA, Hariparsad N, Setchell K, Buckley DJ, Buckley AR, Desai PB. (2003) Dose-dependent induction of cytochrome P450 (CYP) 3A4 and activation of pregnane X receptor by topiramate. Epilepsia44:15211528.
  • Nebert DW, Russell DW. (2002) Clinical importance of the cytochromes P450. Lancet360:11551162.
  • Neligan A, Bell GS, Johnson AL, Goodridge DM, Shorvon SD, Sander JW. (2011) The long-term risk of premature mortality in people with epilepsy. Brain134:388395.
  • Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics6:142.
  • Nikolaos T, Stylianos G, Chryssoula N, Irini P, Christos M, Dimitrios T, Konstantinos P, Antonis T. (2004) The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med Sci Monit10:MT50MT52.
  • Nilsson L, Tomson T, Farahmand BY, Diwan V, Persson PG. (1997) Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy. Epilepsia38:10621068.
  • Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W. (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol72:255260.
  • O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med340:1422.
  • Olesen JB, Abildstrom SZ, Erdal J, Gislason GH, Weeke P, Andersson C, Torp-Pedersen C, Hansen PR. (2011) Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study. Pharmacoepidemiol Drug Saf20:964971.
  • Pack A. (2008) Bone health in people with epilepsy: is it impaired and what are the risk factors?Seizure17:181186.
  • Pack AM, Morrell MJ, Marcus R, Holloway L, Flaster E, Done S, Randall A, Seale C, Shane E. (2005) Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol57:252257.
  • Pack AM, Morrell MJ, Randall A, McMahon DJ, Shane E. (2008) Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology70:15861593.
  • Panegyres PK, Rischbieth RH. (1991) Fatal phenytoin warfarin interaction. Postgrad Med J67:98.
  • Pascussi JM, Robert A, Nguyen M, Walrant-Debray O, Garabedian M, Martin P, Pineau T, Saric J, Navarro F, Maurel P, Vilarem MJ. (2005) Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest115:177186.
  • Pascussi JM, Gerbal-Chaloin S, Duret C, Daujat-Chavanieu M, Vilarem MJ, Maurel P. (2008) The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. Annu Rev Pharmacol Toxicol48:132.
  • Pelkonen O, Turpeinen M, Hakkola J, Honkakoski P, Hukkanen J, Raunio H. (2008) Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol82:667715.
  • Perucca E. (1978) Clinical consequences of microsomal enzyme-induction by antiepileptic drugs. Pharmacol Ther2:285314.
  • Perucca E, Tomson T. (2011) The pharmacological treatment of epilepsy in adults. Lancet Neurol10:446456.
  • Petty SJ, Paton LM, O’Brien TJ, Makovey J, Erbas B, Sambrook P, Berkovic SF, Wark JD. (2005) Effect of antiepileptic medication on bone mineral measures. Neurology65:13581365.
  • Prados MD, Lamborn KR, Chang S, Burton E, Butowski N, Malec M, Kapadia A, Rabbitt J, Page MS, Fedoroff A, Xie D, Kelley SK. (2006) Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Neuro Oncol8:6778.
  • Puduvalli VK, Giglio P, Groves MD, Hess KR, Gilbert MR, Mahankali S, Jackson EF, Levin VA, Conrad CA, Hsu SH, Colman H, de Groot JF, Ritterhouse MG, Ictech SE, Yung WK. (2008) Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme. Neuro Oncol10:216222.
  • Punyawudho B, Cloyd JC, Leppik IE, Ramsay RE, Marino SE, Pennell PB, White JR, Birnbaum AK. (2009) Characterization of the time course of carbamazepine deinduction by an enzyme turnover model. Clin Pharmacokinet48:313320.
  • Pursche S, Schleyer E, von Bonin M, Ehninger G, Said SM, Prondzinsky R, Illmer T, Wang Y, Hosius C, Nikolova Z, Bornhauser M, Dresemann G. (2008) Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients. Curr Clin Pharmacol3:198203.
  • Raizer JJ, Abrey LE, Lassman AB, Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Aldape KD, Wen PY, Fine HA, Mehta M, DeAngelis LM, Lieberman F, Cloughesy TF, Robins HI, Dancey J, Prados MD. (2010) A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas. Neuro Oncol12:8794.
  • Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F. (2005) Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr82:636643.
  • Reardon DA, Quinn JA, Vredenburgh JJ, Gururangan S, Friedman AH, Desjardins A, Sathornsumetee S, Herndon JE, Dowell JM, McLendon RE, Provenzale JM, Sampson JH, Smith RP, Swaisland AJ, Ochs JS, Lyons P, Tourt-Uhlig S, Bigner DD, Friedman HS, Rich JN. (2006) Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma. Clin Cancer Res12:860868.
  • Reardon DA, Desjardins A, Vredenburgh JJ, Gururangan S, Friedman AH, Herndon JE, Marcello J, Norfleet JA, McLendon RE, Sampson JH, Friedman HS. (2010) Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma. J Neurooncol96:219230.
  • Reitman ML, Chu X, Cai X, Yabut J, Venkatasubramanian R, Zajic S, Stone JA, Ding Y, Witter R, Gibson C, Roupe K, Evers R, Wagner JA, Stoch A. (2011) Rifampin’s acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug–drug interaction trial design. Clin Pharmacol Ther89:234242.
  • Relling MV, Pui CH, Sandlund JT, Rivera GK, Hancock ML, Boyett JM, Schuetz EG, Evans WE. (2000) Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet356:285290.
  • Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK. (2007) Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst99:592600.
  • Riechelmann RP, Zimmermann C, Chin SN, Wang L, O’Carroll A, Zarinehbaf S, Krzyzanowska MK. (2008) Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage35:535543.
  • Rodman JH, Murry DJ, Madden T, Santana VM. (1994) Altered etoposide pharmacokinetics and time to engraftment in pediatric patients undergoing autologous bone marrow transplantation. J Clin Oncol12:23902397.
  • Rosenfeld WE, Doose DR, Walker SA, Nayak RK. (1997) Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Epilepsia38:317323.
  • Roste LS, Tauboll E, Haugen TB, Bjornenak T, Saetre ER, Gjerstad L. (2003) Alterations in semen parameters in men with epilepsy treated with valproate or carbamazepine monotherapy. Eur J Neurol10:501506.
  • Santisteban M, Buckner JC, Reid JM, Wu W, Scheithauer BW, Ames MM, Felten SJ, Nikcevich DA, Wiesenfeld M, Jaeckle KA, Galanis E. (2009) Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results. J Neurooncol92:165175.
  • Schaffler L, Bourgeois BF, Luders HO. (1994) Rapid reversibility of autoinduction of carbamazepine metabolism after temporary discontinuation. Epilepsia35:195198.
  • Schwaninger M, Ringleb P, Annecke A, Winter R, Kohl B, Werle E, Fiehn W, Rieser PA, Walter-Sack I. (2000) Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patients. J Neurol247:687690.
  • Sheth RD, Wesolowski CA, Jacob JC, Penney S, Hobbs GR, Riggs JE, Bodensteiner JB. (1995) Effect of carbamazepine and valproate on bone mineral density. J Pediatr127:256262.
  • Sillanpaa M, Schmidt D. (2006) Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain129:617624.
  • Silver J, Neale G, Thompson GR. (1974) Effect of phenobarbitone treatment on vitamin D metabolism in mammals. Clin Sci Mol Med46:433448.
  • Sonmez FM, Demir E, Orem A, Yildirmis S, Orhan F, Aslan A, Topbas M. (2006) Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes. J Child Neurol21:7074.
  • Souverein PC, Webb DJ, Petri H, Weil J, Van Staa TP, Egberts T. (2005) Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database. Epilepsia46:304310.
  • Souverein PC, Webb DJ, Weil JG, Van Staa TP, Egberts AC. (2006) Use of antiepileptic drugs and risk of fractures: case–control study among patients with epilepsy. Neurology66:13181324.
  • Spina E, Perucca E. (2002) Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia43(Suppl. 2):3744.
  • Spina E, Pisani F, Perucca E. (1996) Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet31:198214.
  • Stephen LJ, McLellan AR, Harrison JH, Shapiro D, Dominiczak MH, Sills GJ, Brodie MJ. (1999) Bone density and antiepileptic drugs: a case–controlled study. Seizure8:339342.
  • Stjernholm MR, Katz FH. (1975) Effects of diphenylhydantoin, phenobarbital, and diazepam on the metabolism of methylprednisolone and its sodium succinate. J Clin Endocrinol Metab41:887893.
  • Strack DK, Leckband SG, Meyer JM. (2009) Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine. J Psychiatr Pract15:442448.
  • Tan TY, Lu CH, Chuang HY, Lin TK, Liou CW, Chang WN, Chuang YC. (2009) Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis. Epilepsia50:15791586.
  • Tomoum HY, Awadallah MM, Fouad DA, Ali AH. (2008) Lipid profile, apolipoproteins A and B in children with epilepsy. J Child Neurol23:12751281.
  • Tompkins LM, Wallace AD. (2007) Mechanisms of cytochrome P450 induction. J Biochem Mol Toxicol21:176181.
  • Tomson T, Svensson JO, Hilton-Brown P. (1989) Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism. Ther Drug Monit11:533539.
  • Tsiropoulos I, Andersen M, Nymark T, Lauritsen J, Gaist D, Hallas J. (2008) Exposure to antiepileptic drugs and the risk of hip fracture: a case–control study. Epilepsia49:20922099.
  • Ucar M, Neuvonen M, Luurila H, Dahlqvist R, Neuvonen PJ, Mjorndal T. (2004) Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid. Eur J Clin Pharmacol59:879882.
  • Vecht CJ, Wagner GL, Wilms EB. (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol2:404409.
  • Verrotti A, Basciani F, Domizio S, Sabatino G, Morgese G, Chiarelli F. (1998) Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr Neurol19:364367.
  • Verrotti A, Greco R, Morgese G, Chiarelli F. (2000a) Increased bone turnover in epileptic patients treated with carbamazepine. Ann Neurol47:385388.
  • Verrotti A, Pascarella R, Trotta D, Giuva T, Morgese G, Chiarelli F. (2000b) Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Res41:253257.
  • Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F. (2002) Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia43:14881492.
  • Verrotti A, Loiacono G, Laus M, Coppola G, Chiarelli F, Tiboni GM. (2011) Hormonal and reproductive disturbances in epileptic male patients: emerging issues. Reprod Toxicol31:519527.
  • Vestergaard P, Rejnmark L, Mosekilde L. (2004) Fracture risk associated with use of antiepileptic drugs. Epilepsia45:13301337.
  • Villikka K, Kivisto KT, Maenpaa H, Joensuu H, Neuvonen PJ. (1999) Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. Clin Pharmacol Ther66:589593.
  • Vredenburgh JJ, Desjardins A, Herndon JE, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS. (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol25:47224729.
  • Wada K, Takada M, Ueda T, Ochi H, Kotake T, Morishita H, Hanatani A, Nakatani T. (2007) Drug interactions between tacrolimus and phenytoin in Japanese heart transplant recipients: 2 case reports. Int J Clin Pharmacol Ther45:524528.
  • Wang SP, Mintzer S, Skidmore CT, Zhan T, Stuckert E, Nei M, Sperling MR. (2012) Seizure recurrence and remission after switching antiepileptic drugs. Epilepsia doi:10.1111/j.1528-1167.2012.03652.x.
  • Xu RX, Lambert MH, Wisely BB, Warren EN, Weinert EE, Waitt GM, Williams JD, Collins JL, Moore LB, Willson TM, Moore JT. (2004) A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol Cell16:919928.
  • Zhou C, Assem M, Tay JC, Watkins PB, Blumberg B, Schuetz EG, Thummel KE. (2006) Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest116:17031712.
  • Zhu BT. (2010) On the general mechanism of selective induction of cytochrome P450 enzymes by chemicals: some theoretical considerations. Expert Opin Drug Metab Toxicol6:483494.
  • Zhu M, Kaul S, Nandy P, Grasela DM, Pfister M. (2009) Model-based approach to characterize efavirenz autoinduction and concurrent enzyme induction with carbamazepine. Antimicrob Agents Chemother53:23462353.